A comparative study of intralesional injection of Candida albicans antigen, bleomycin and 5-fluorouracil for treatment of plane warts

Authors:

Abstract
Background: Several therapeutic modalities for treatment of verruca plana (VP) are available, but none has achieved complete cure in all cases with associated risk of side effects. Objective: To evaluate efficacy and safety of intralesional injection of candida albicans (C.albican) antigen, bleomycin and 5- fluorouracil (5-FU) in treatment of VP. Methods: 60 patients with VP were randomly divided into 3 equal groups who were treated using C.albicans antigen, bleomycin or 5- FU injections every 2 weeks till complete clearance of the lesions or for a maximum of 4 sessions and followed up for additional 8 weeks. Results: A statistically significant higher incidence of complete response was achieved with bleomycin (85%) than C.albicans antigen (60%) which was higher than 5-FU (45%) with a significantly less number of required sessions to achieve best results with bleomycin and candida antigen than 5-FU. Conclusions: C.albicans antigen, bleomycin and 5-FU are helpful modalities for treatment of VP. Bleomycin was the most effective, followed by C.albicans antigen then 5-FU (least effective). Single injection site, clearance of distant warts and decreased incidence of new lesion development - insitu or elsewhere - are additional merits of C.albicans immunotherapy. These modalities are cheap with only transient adverse effects.

This publication has 19 references indexed in Scilit: